BIOMAT Database Logo BIOMAT Database Logo

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. 1994

P C Brooks, and A M Montgomery, and M Rosenfeld, and R A Reisfeld, and T Hu, and G Klier, and D A Cheresh
Department of Immunology, Scripps Research Institute, La Jolla, California 92037.

A single intravascular injection of a cyclic peptide or monoclonal antibody antagonist of integrin alpha v beta 3 disrupts ongoing angiogenesis on the chick chorioallantoic membrane (CAM). This leads to the rapid regression of histologically distinct human tumors transplanted onto the CAM. Induction of angiogenesis by a tumor or cytokine promotes vascular cell entry into the cell cycle and expression of integrin alpha v beta 3. After angiogenesis is initiated, antagonists of this integrin induce apoptosis of the proliferative angiogenic vascular cells, leaving preexisting quiescent blood vessels unaffected. We demonstrate therefore that ligation of integrin alpha v beta 3 is required for the survival and maturation of newly forming blood vessels, an event essential for the proliferation of tumors.

UI MeSH Term Description Entries
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D009389 Neovascularization, Pathologic A pathologic process consisting of the proliferation of blood vessels in abnormal tissues or in abnormal positions. Angiogenesis, Pathologic,Angiogenesis, Pathological,Neovascularization, Pathological,Pathologic Angiogenesis,Pathologic Neovascularization,Pathological Angiogenesis,Pathological Neovascularization
D001808 Blood Vessels Any of the tubular vessels conveying the blood (arteries, arterioles, capillaries, venules, and veins). Blood Vessel,Vessel, Blood,Vessels, Blood
D002642 Chick Embryo The developmental entity of a fertilized chicken egg (ZYGOTE). The developmental process begins about 24 h before the egg is laid at the BLASTODISC, a small whitish spot on the surface of the EGG YOLK. After 21 days of incubation, the embryo is fully developed before hatching. Embryo, Chick,Chick Embryos,Embryos, Chick
D002823 Chorion The outermost extra-embryonic membrane surrounding the developing embryo. In REPTILES and BIRDS, it adheres to the shell and allows exchange of gases between the egg and its environment. In MAMMALS, the chorion evolves into the fetal contribution of the PLACENTA. Chorions
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000482 Allantois An extra-embryonic membranous sac derived from the YOLK SAC of REPTILES; BIRDS; and MAMMALS. It lies between two other extra-embryonic membranes, the AMNION and the CHORION. The allantois serves to store urinary wastes and mediate exchange of gas and nutrients for the developing embryo. Allantoic Membrane,Membrane, Allantoic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured

Related Publications

P C Brooks, and A M Montgomery, and M Rosenfeld, and R A Reisfeld, and T Hu, and G Klier, and D A Cheresh
Integrin alpha v beta 3 antagonists for anti-angiogenic cancer treatment.
June 2007, Recent patents on anti-cancer drug discovery,
P C Brooks, and A M Montgomery, and M Rosenfeld, and R A Reisfeld, and T Hu, and G Klier, and D A Cheresh
Integrin alpha(v)beta(3)-mediated activation of apoptosis.
August 1999, Experimental cell research,
P C Brooks, and A M Montgomery, and M Rosenfeld, and R A Reisfeld, and T Hu, and G Klier, and D A Cheresh
Expression of integrin alpha v beta 3 in small blood vessels of glioblastoma tumors.
November 1996, Journal of neuropathology and experimental neurology,
P C Brooks, and A M Montgomery, and M Rosenfeld, and R A Reisfeld, and T Hu, and G Klier, and D A Cheresh
Isoxazolines as potent antagonists of the integrin alpha(v)beta(3).
January 2000, Journal of medicinal chemistry,
P C Brooks, and A M Montgomery, and M Rosenfeld, and R A Reisfeld, and T Hu, and G Klier, and D A Cheresh
Binding model for nonpeptide antagonists of alpha(v)beta(3) integrin.
December 2002, Journal of medicinal chemistry,
P C Brooks, and A M Montgomery, and M Rosenfeld, and R A Reisfeld, and T Hu, and G Klier, and D A Cheresh
alpha(v)beta(3) Integrin antagonists as inhibitors of bone resorption.
June 2000, Expert opinion on investigational drugs,
P C Brooks, and A M Montgomery, and M Rosenfeld, and R A Reisfeld, and T Hu, and G Klier, and D A Cheresh
REVIEW: the integrin alpha V beta 3: angiogenesis and apoptosis.
November 1995, Cell adhesion and communication,
P C Brooks, and A M Montgomery, and M Rosenfeld, and R A Reisfeld, and T Hu, and G Klier, and D A Cheresh
Disubstituted indazoles as potent antagonists of the integrin alpha(v)beta(3).
January 2000, Journal of medicinal chemistry,
P C Brooks, and A M Montgomery, and M Rosenfeld, and R A Reisfeld, and T Hu, and G Klier, and D A Cheresh
An antagonist of integrin alpha v beta 3 prevents maturation of blood vessels during embryonic neovascularization.
July 1995, Journal of cell science,
P C Brooks, and A M Montgomery, and M Rosenfeld, and R A Reisfeld, and T Hu, and G Klier, and D A Cheresh
Nonpeptide alpha(v)beta(3) antagonists. 1. Transformation of a potent, integrin-selective alpha(IIb)beta(3) antagonist into a potent alpha(v)beta(3) antagonist.
October 2000, Journal of medicinal chemistry,
Copied contents to your clipboard!